Efficacy and safety of Phlai capsule for allergic rhinitis: a randomized, double-blind, placebo-controlled study
M. Hoang (Bangkok, Thailand), K. Seresirikachorn (Bangkok, Thailand), S. Kerr (Bangkok, Thailand), J. Kanjanaumporn (Bangkok, Thailand), S. Aeumjaturapat (Bangkok, Thailand), S. Chusakul (Bangkok, Thailand), J. Samuthpongtorn (Bangkok, Thailand), W. Chitsuthipakorn (Bangkok, Thailand), P. Kasemsiri (Khon Kaen, Thailand), V. Kirtsreesakul (Hat Yai, Thailand), K. Prasittivatechakool (Bangkok, Thailand), P. Tantilipikorn (Bangkok, Thailand), O. Poachanukoon (Pathum Thani, Thailand), K. Snidvongs (Bangkok, Thailand)
Source: International Congress 2022 – Update on clinical trials in allergy, asthma and COPD
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Hoang (Bangkok, Thailand), K. Seresirikachorn (Bangkok, Thailand), S. Kerr (Bangkok, Thailand), J. Kanjanaumporn (Bangkok, Thailand), S. Aeumjaturapat (Bangkok, Thailand), S. Chusakul (Bangkok, Thailand), J. Samuthpongtorn (Bangkok, Thailand), W. Chitsuthipakorn (Bangkok, Thailand), P. Kasemsiri (Khon Kaen, Thailand), V. Kirtsreesakul (Hat Yai, Thailand), K. Prasittivatechakool (Bangkok, Thailand), P. Tantilipikorn (Bangkok, Thailand), O. Poachanukoon (Pathum Thani, Thailand), K. Snidvongs (Bangkok, Thailand). Efficacy and safety of Phlai capsule for allergic rhinitis: a randomized, double-blind, placebo-controlled study. 3208
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|